Optimizing Tuberculosis Diagnosis: The Role of GeneXpert in Smear-Negative Cases
Abstract
Objective: To observe the efficiency of GeneXpert in confirmation of smear negative pulmonary TB cases.Methods
This descriptive study was conducted at HRI-NIH TB Research Centre King Edward Medical University/ rd th Mayo Hospital Lahore during 23 December 2020 to 26 May 2021. Those smear negative patients who already started their anti-tubercular treatment and coming for follow-up were not included in this study. After taking informed consent patients suspected of having pulmonary tuberculosis on clinical and radiological grounds but negative sputum smear microscopy were asked to provide a spot sputum specimen in a sterile container and GeneXpert MTB/RIF assay was performed.Results
A total of 116 smear negative patients consisted of 64 (55.2%) females and 52 (44.8%) males with male to female ratio of 1:1.23. Mean age of patients was 39.7±15.46 with minimum age of patients as 18 years and maximum of 72 years. Presenting complaints were also recorded; low grade fever and weight loss were present in 100% patients while fatigue was also present in 90.5% patients and anorexia in 83.6% cases. A total of 21 (18.0%) smear negative patients came back as positive for MTB on GeneXpert; of these 13/21 (61.9%) were reported as showing very low quantity and remaining 8/21 (38.1%) showed low quantity while none of the patients showed Rifampicin resistance on GeneXpert.Conclusion
Diagnostic delay of smear negative pulmonary TB could be improved by using GeneXpert as 18% smear negative TB cases were confirmed by using this technique in this study which ultimately can prevent considerable morbidity and mortality.Keywords:
Tuberculosis, GeneXpert, Early diagnosis, AFB smear.Published
2025/06/05
Issue
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments psimjournal@gmail.com